Bicara Therapeutics Inc. Common Stock Working Capital to Net Assets Ratio
Bicara Therapeutics Inc. Common Stock working capital to net assets ratio. Bicara Therapeutics Inc. Common Stock (BCAX) has a Working Capital to Net Assets ratio of 98.2% as of June 2026. Working capital of $460.35 Million (current assets of $503.82 Million minus current liabilities of $43.48 Million) is measured against net assets of $468.77 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Bicara Therapeutics Inc. Common Stock tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Bicara Therapeutics Inc. Common Stock (2022–2025)
Working capital to net assets ratio of Bicara Therapeutics Inc. Common Stock from 2022 to 2025. This chart shows how Bicara Therapeutics Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 98.2%, reflecting working capital of $460.35 Million against net assets of $468.77 Million USD. See Bicara Therapeutics Inc. Common Stock defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Bicara Therapeutics Inc. Common Stock Working Capital to Net Assets Ratio by Year (2022–2025)
Bicara Therapeutics Inc. Common Stock working capital to net assets ratio by year from 2022 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Bicara Therapeutics Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see BCAX total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 97.9% | $393.10 Million | $401.45 Million | $422.05 Million | $28.95 Million | ▼ -0.6 pp |
| 2024 | 98.5% | $484.54 Million | $491.88 Million | $502.53 Million | $17.99 Million | ▼ -0.3 pp |
| 2023 | 98.8% | $215.99 Million | $218.51 Million | $231.07 Million | $15.09 Million | ▼ -10.6 pp |
| 2022 | 109.5% | $-18.91 Million | $-17.28 Million | $4.98 Million | $23.90 Million | — |